1.7 USD
-0.03 (-1.73%)
ChartMill assigns a Buy % Consensus number of 90% to CLYM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.38. This target is 452% above the current price.
CLYM was analyzed by 12 analysts. The buy percentage consensus is at 90. So analysts seem to be very confident about CLYM.
In the previous month the buy percentage consensus was at a similar level.
CLYM was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-16 | William Blair | Initiate | Outperform |
| 2025-10-16 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-13 | HC Wainwright & Co. | Initiate | Buy |
| 2025-09-30 | BTIG | Maintains | Buy -> Buy |
| 2025-09-22 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-15 | Baird | Initiate | Outperform |
| 2025-06-06 | Oppenheimer | Initiate | Outperform |
CLIMB BIO INC / CLYM FAQ
Can you provide the average price target for CLIMB BIO INC stock?
12 analysts have analysed CLYM and the average price target is 9.38 USD. This implies a price increase of 452% is expected in the next year compared to the current price of 1.7.
What is the consensus rating for CLYM stock?
The consensus rating for CLIMB BIO INC (CLYM) is 90 / 100 . This indicates that analysts generally have a positive outlook on the stock.